Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.3600 (-0.8%) ($94.3600 - $95.3400) on Wed. Jul. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.56% (three month average) | RSI | 77 | Latest Price | $94.3600(-0.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 4.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(51%) IWN(50%) IWO(50%) IBB(49%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.78% in a week (0% probabilities). UUP(-16%) VXX(-15%) VIXM(-9%) TBT(-7%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.78% (StdDev 3.56%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $94.65(-0.31%) | 10 Day Moving Average | $93.29(1.15%) | 20 Day Moving Average | $88.09(7.12%) | To recent high | -14% | To recent low | 26.8% | Market Cap | $1.516b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |